the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Volume Index of Services experienced robust growth of 6.7% in Q2 2024 – DOSM

PUTRAJAYA: The Volume Index of Services experienced a robust 6.7% growth in the second quarter (Q2) of 2024, recording 152.2 points, according to the Volume Index of Services, Second Quarter 2024, released today by the Department of Statistics Malaysia (DOSM).

Chief Statistician Datuk Seri Dr Mohd Uzir Mahidin in a statement today said the performance of the Volume Index of Services for Q2 2024 was attributed to the growth in the business services and finance segment which experienced a 10.4% increase to reach 144.7 points, followed by wholesale & retail trade, food & beverage and accommodation segment which registered a growth of 5.1% to reach 152.6 points.

“In the same period, the information & communication and transportation & storage segment rose 6.0% to stand at 167.8 points, while other services segment grew 7.4%,” he said.

For quarter-on-quarter comparison, he said the Volume Index of Services had a 1.2% increase in Q2 2024, supported by the increase in wholesale & retail trade, food & beverage and accommodation segment, followed by information & communication and transportation & storage segment (1.8%), and other services segment (0.9%).

However, the business services and finance segment decreased by 0.1%, he said.

Mohd Uzir said that the seasonally adjusted volume index increased by 3.9% compared to Q1 2024, resulting from the increase in wholesale & retail trade, food & beverage and accommodation segment (4.9%); business services and finance segment (3.3%); information & communication and transportation & storage segment (1.9%), and other services segment (5.7%).

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings